Skip to main
RDY

RDY Earnings Dates & Reports

RDY Most Recent Earnings

Report Date
Period EndingQ4 2026
Est. EPS$0.09
Actual EPS$0.03
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RDY Earnings per Share (EPS) History

Signup for full access
Browse free

RDY Latest Earnings

The value each RDY share was expected to gain vs. the value each share gained.

RDY reported its most recent earnings on for Q4 2026, posting earnings per share (EPS) of $0.03. This exceeded analysts' expectations of $0.09 by 67.78%, marking a Miss.

For comparison, Dr. Reddy's Labs reported EPS of $0.22 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.17.

RDY Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2027
$0.17
Q4 2026
$0.09$0.03-67.78%
Q3 2026
$0.16$0.16+1.88%
Q2 2026
$0.18$0.19+5.56%
Q1 2026
$0.18$0.20+11.11%
View all

RDY Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Dr. Reddy's Labs’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

RDY Earnings FAQs

RDY last reported earnings on May 12, 2026 for Q4 2026, posting an EPS of $0.03, which Miss the estimate of $0.09 by 67.78%.

For Q4 2026, RDY reported an EPS of $0.03, missing analysts' estimate of $0.09 by 67.78%.

For Q4 2026, RDY Miss expectations with an actual EPS of $0.03 vs. an estimated EPS of $0.09.

Following the last earnings report on May 12, 2026, RDY's stock price moved — from — to —.

The next RDY earnings call is scheduled for Jul. 22, 2026, where executives will discuss financial results and outlook.

Dr. Reddy's Labs (RDY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.